By contrast, biomarkers which have been associated with responses to ICIs include PD-L1 expression in stromal cells,16 CD28 expression on CD8+ tumor-infiltrating lymphocytes (TILs),37 and stromal TILs.38 The gene discussed is CD28; the disease is neoplasm.